Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy

Por Nguyen, HuyTram N., Lie, Amy, Li, Tie, Chowdhury, Reshmi, Liu, Fei, Ozer, Byram, Wei, Bowen, Green, Richard M., Ellingson, Benjamin M., Wang, He-jing, Elashoff, Robert, Liau, Linda M., Yong, William H., Nghiemphu, Phioanh L., Cloughesy, Timothy, Lai, Albert
Publicado no Neuro Oncol (2017)